Anthelmintic Drugs Global Market Report 2026

Description

Anthelmintic drugs are medications designed to treat infections caused by parasitic worms, known as helminths. These drugs function by either destroying the worms or interfering with their ability to reproduce and survive. They are commonly used to manage infections such as roundworm, tapeworm, and hookworm infestations.

The primary classes of anthelmintic drugs include benzimidazoles, macrocyclic lactones, pyrazinoisoquinolones, tetrahydropyrimidines, and others. Benzimidazoles are a group of organic compounds featuring a benzene ring fused to an imidazole ring. They are widely used in multiple applications, including as pharmaceutical agents for the treatment of parasitic infections and as important components in certain synthetic materials. These drugs are administered through oral and injectable routes to treat a range of infections, including nematode, cestode, trematode, and mixed infections. They are distributed through channels such as hospitals and clinics, retail pharmacies, online pharmacies, veterinary clinics, and supply stores, and are used in both human and veterinary anthelmintic applications.

Tariffs have impacted the anthelmintic drugs market by increasing the cost of imported active pharmaceutical ingredients and finished drugs, which has affected both human and veterinary segments. Oral and injectable formulations imported from Asia-Pacific regions such as India and China are most affected, leading to higher treatment costs and supply chain delays. On the positive side, tariffs have encouraged domestic production, local manufacturing of generic anthelmintics, and innovation in combination and broad-spectrum drug formulations.

The anthelmintic drugs market research report is one of a series of new reports from The Business Research Company that provides anthelmintic drugs market statistics, including anthelmintic drugs industry global market size, regional shares, competitors with a anthelmintic drugs market share, detailed anthelmintic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anthelmintic drugs industry. This anthelmintic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anthelmintic drugs market size has grown strongly in recent years. It will grow from $3.34 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence of parasitic infections, limited access to advanced anthelmintic drugs, reliance on traditional drug classes, growing awareness of helminth infections, expanding hospital and clinic infrastructure.

The anthelmintic drugs market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to development of novel anthelmintic compounds, increasing adoption of combination therapies, rising veterinary and livestock applications, expansion of online and retail pharmacy channels, government initiatives for parasite control programs. Major trends in the forecast period include rising prevalence of helminth infections in humans and animals, growing adoption of oral anthelmintics and injectable formulations, increasing demand for veterinary anthelmintics in livestock management, expansion of retail and online pharmacy channels for anthelmintic drugs, focus on combination therapies and broad-spectrum anthelmintics.

The widespread prevalence of parasitic infections is expected to drive the growth of the anthelmintic drugs market in the coming years. Parasitic infections are illnesses caused by organisms that live on or within a host, including parasites such as protozoa, worms, or ectoparasites. The occurrence of parasitic infections is driven by factors such as poor sanitation, contaminated food and water, close contact with infected humans or animals, insufficient hygiene practices, and limited access to clean resources. Anthelmintic drugs are used to treat infections caused by parasitic worms by effectively targeting and removing these organisms from the host's body. These drugs act by interfering with the parasites' biological processes, ultimately resulting in their expulsion or death. For example, in September 2025, according to data published by the Centers for Disease Control and Prevention, a US-based national public health agency, as of September 16, 2025, the CDC had received reports of 990 cases of cyclosporiasis acquired within the United States. Therefore, the high prevalence of parasitic infections is contributing to the growth of the anthelmintic drugs market.

Leading companies operating in the anthelmintic drugs market are emphasizing the development of innovative approaches, such as targeted and evidence-based deworming programs, to enhance parasite control, limit drug resistance, and encourage the sustainable use of anthelmintics compared with conventional blanket deworming strategies that often depend on frequent, non-targeted treatments. Targeted deworming programs utilize diagnostic testing, parasite burden evaluation, and planned dosing regimens to maximize treatment effectiveness while reducing environmental impact and resistance risks. For instance, in April 2025, Zoetis Inc., a US-based animal health company, introduced the "Buy Less Dewormer" campaign for equine populations, promoting evidence-based parasite management. This initiative integrates educational resources with guidance on fecal egg count monitoring and strategic selection of anthelmintics, encouraging veterinarians and horse owners to administer treatments only when necessary based on parasite load and risk assessment. Key features include comprehensive educational materials, risk-based treatment guidance, and support for sustainable anthelmintic stewardship, with applications in equine herd health management, resistance prevention, and optimized deworming schedules. The benefits include reduced overuse of anthelmintic drugs, improved parasite control outcomes, lower costs for owners, and preservation of long-term drug effectiveness.

In July 2023, Bayer AG, a Germany-based pharmaceutical and biotechnology company, entered into a partnership with the Swiss Tropical and Public Health Institute (Swiss TPH) to develop anthelmintic drug candidates for the treatment of parasitic infections. This collaboration is focused on assessing the safety and effectiveness of emodepside, a compound originally developed for veterinary applications, for use in treating soil-transmitted helminths in humans. The partnership aims to introduce a new therapeutic option and support global health initiatives by addressing a significant public health issue in developing regions. The Swiss Tropical and Public Health Institute (Swiss TPH) is a Switzerland-based research organization specializing in global health and tropical disease research.

Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

North America was the largest region in the anthelmintic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anthelmintic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anthelmintic drugs market consists of sales of albendazole, mebendazole, praziquantel, levamisole, piperazine, and ivermectin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anthelmintic Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses anthelmintic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anthelmintic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anthelmintic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Drug Class: Benzimidazoles; Macrocyclic lactones; Pyrazinoisoquinolones; Tetrahydropyrimidines; Other Drug Classes
2) By Route Of Administration: Oral; Injectable
3) By Infection Type: Nematode Infections; Cestode Infections; Trematode Infections; Mixed Infections
4) By Distribution Channel: Hospitals And Clinics; Retail Pharmacies; Online Pharmacies; Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics; Veterinary Anthelmintics
Subsegments:
1) By Benzimidazoles: Albendazole; Mebendazole; Fenbendazole; Oxfendazole; Thiabendazole
2) By Macrocyclic Lactones: Ivermectin; Moxidectin; Doramectin; Eprinomectin; Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel; Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate; Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles; Aminoacetonitrile Derivatives; Spiroindoles; Arsenicals
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; Novartis AG; GlaxoSmithKline plc; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Limited; Zoetis Inc.; Hetero Labs Limited; Sun Pharmaceutical Industries Ltd.; Galderma S.A.; Cipla Inc.; Ferring Pharmaceuticals Inc.; Amneal Pharmaceuticals Inc.; Zydus Lifesciences Limited; Glenmark Pharmaceuticals Ltd.; Mankind Pharma Ltd.; Reese Pharmaceutical Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH5MADRU11_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Anthelmintic Drugs Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Anthelmintic Drugs Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Anthelmintic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Anthelmintic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Rising Prevalence Of Helminth Infections In Humans And Animals
- 4.2.2 Growing Adoption Of Oral Anthelmintics And Injectable Formulations
- 4.2.3 Increasing Demand For Veterinary Anthelmintics In Livestock Management
- 4.2.4 Expansion Of Retail And Online Pharmacy Channels For Anthelmintic Drugs
- 4.2.5 Focus On Combination Therapies And Broad-Spectrum Anthelmintics

5. Anthelmintic Drugs Market Analysis Of End Use Industries

5.1 Hospitals And Clinics
5.2 Retail Pharmacies
5.3 Online Pharmacies
5.4 Veterinary Clinics And Supply Stores
5.5 Livestock Farms

6. Anthelmintic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anthelmintic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anthelmintic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Anthelmintic Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Anthelmintic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Anthelmintic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anthelmintic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anthelmintic Drugs Market Segmentation

9.1. Global Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Benzimidazoles, Macrocyclic Lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
9.2. Global Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Injectable
9.3. Global Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
9.4. Global Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
9.5. Global Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Anthelmintics, Veterinary Anthelmintics
9.6. Global Anthelmintic Drugs Market, Sub-Segmentation Of Benzimidazoles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
9.7. Global Anthelmintic Drugs Market, Sub-Segmentation Of Macrocyclic Lactones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
9.8. Global Anthelmintic Drugs Market, Sub-Segmentation Of Pyrazinoisoquinolones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Praziquantel, Cysticide
9.9. Global Anthelmintic Drugs Market, Sub-Segmentation Of Tetrahydropyrimidines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pyrantel Pamoate, Pyrantel Tartrate
9.10. Global Anthelmintic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

10. Anthelmintic Drugs Market Regional And Country Analysis

10.1. Global Anthelmintic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Anthelmintic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anthelmintic Drugs Market

11.1. Asia-Pacific Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anthelmintic Drugs Market

12.1. China Anthelmintic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anthelmintic Drugs Market

13.1. India Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anthelmintic Drugs Market

14.1. Japan Anthelmintic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anthelmintic Drugs Market

15.1. Australia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anthelmintic Drugs Market

16.1. Indonesia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anthelmintic Drugs Market

17.1. South Korea Anthelmintic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anthelmintic Drugs Market

18.1. Taiwan Anthelmintic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anthelmintic Drugs Market

19.1. South East Asia Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anthelmintic Drugs Market

20.1. Western Europe Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anthelmintic Drugs Market

21.1. UK Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anthelmintic Drugs Market

22.1. Germany Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anthelmintic Drugs Market

23.1. France Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anthelmintic Drugs Market

24.1. Italy Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anthelmintic Drugs Market

25.1. Spain Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anthelmintic Drugs Market

26.1. Eastern Europe Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anthelmintic Drugs Market

27.1. Russia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anthelmintic Drugs Market

28.1. North America Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anthelmintic Drugs Market

29.1. USA Anthelmintic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anthelmintic Drugs Market

30.1. Canada Anthelmintic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anthelmintic Drugs Market

31.1. South America Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anthelmintic Drugs Market

32.1. Brazil Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anthelmintic Drugs Market

33.1. Middle East Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anthelmintic Drugs Market

34.1. Africa Anthelmintic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anthelmintic Drugs Market Regulatory and Investment Landscape

36. Anthelmintic Drugs Market Competitive Landscape And Company Profiles

36.1. Anthelmintic Drugs Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Anthelmintic Drugs Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Anthelmintic Drugs Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Anthelmintic Drugs Market Other Major And Innovative Companies

Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd.

38. Global Anthelmintic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anthelmintic Drugs Market

40. Anthelmintic Drugs Market High Potential Countries, Segments and Strategies

40.1 Anthelmintic Drugs Market In 2030 - Countries Offering Most New Opportunities
40.2 Anthelmintic Drugs Market In 2030 - Segments Offering Most New Opportunities
40.3 Anthelmintic Drugs Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer